Emma Johnson

Emma Johnson is a prominent figure in the life sciences investment sector, currently serving as Co-Founder and Board Member of Invest In Equity, which aims to enhance gender equity in investment roles. Johnson has extensive board experience, holding positions at organizations such as Maxion Therapeutics, OMass Therapeutics, Purespring Therapeutics, Tenpoint Therapeutics Ltd, Epsilogen Ltd, Nucleome Therapeutics, and Grey Wolf Therapeutics. Additionally, Johnson is a Senior Investment Manager at the British Business Bank, where responsibilities include leading venture capital investments in UK life sciences companies. Johnson holds a Master of Science in Cognitive Neuroscience from UCL and a Bachelor of Science in Neuroscience from the University of Bristol.